Publication

Empagliflozin improves metabolic and hepatic outcomes in a non-diabetic obese biopsy-proven mouse model of advanced NASH

International Journal of Molecular Sciences 22:6332, 2021

Perakakis N, Chrysafi P, Feigh M, Veidal SS, Mantzoros CS

Share this page

Resource Library

Related resources

Experimental non-alcoholic steatohepatitis in Göttingen Minipigs: consequences of high fat-fructose-cholesterol diet and diabetes

Validity of biopsy-based drug effects in a diet-induced obese mouse model of biopsy-confirmed NASH

Metabolic, biochemical and histological characterization of a CDAA-HFD-induced non-obese rat model of advanced NASH with progressive fibrosis

Activation of thyroid hormone receptor-β improved disease activity and metabolism independent of body weight in a mouse model of non-alcoholic steatohepatitis and fibrosis

For further information

Contact us

Gubra

Hørsholm Kongevej 11B
2970 Hørsholm
Denmark

+45 3152 2650